Akhmedov, A.; Terenteva, O.; Subakaeva, E.; Zelenikhin, P.; Shurpik, R.; Shurpik, D.; Padnya, P.; Stoikov, I.
Fluorescein-Labeled Thiacalix[4]arenes as Potential Theranostic Molecules: Synthesis, Self-Association, and Antitumor Activity. Pharmaceutics 2022, 14, 2340.
https://doi.org/10.3390/pharmaceutics14112340
AMA Style
Akhmedov A, Terenteva O, Subakaeva E, Zelenikhin P, Shurpik R, Shurpik D, Padnya P, Stoikov I.
Fluorescein-Labeled Thiacalix[4]arenes as Potential Theranostic Molecules: Synthesis, Self-Association, and Antitumor Activity. Pharmaceutics. 2022; 14(11):2340.
https://doi.org/10.3390/pharmaceutics14112340
Chicago/Turabian Style
Akhmedov, Alan, Olga Terenteva, Evgenia Subakaeva, Pavel Zelenikhin, Ramilia Shurpik, Dmitriy Shurpik, Pavel Padnya, and Ivan Stoikov.
2022. "Fluorescein-Labeled Thiacalix[4]arenes as Potential Theranostic Molecules: Synthesis, Self-Association, and Antitumor Activity" Pharmaceutics 14, no. 11: 2340.
https://doi.org/10.3390/pharmaceutics14112340
APA Style
Akhmedov, A., Terenteva, O., Subakaeva, E., Zelenikhin, P., Shurpik, R., Shurpik, D., Padnya, P., & Stoikov, I.
(2022). Fluorescein-Labeled Thiacalix[4]arenes as Potential Theranostic Molecules: Synthesis, Self-Association, and Antitumor Activity. Pharmaceutics, 14(11), 2340.
https://doi.org/10.3390/pharmaceutics14112340